These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38821630)

  • 1.
    Denomme N; Hernandez CC; Bock HA; Ohana RF; Bakshi S; Sherwood AM; McCorvy JD; Daley PF; Callaway WB; Hull JM; Alt A; Isom LL; Cozzi NV
    Mol Pharmacol; 2024 Jul; 106(2):92-106. PubMed ID: 38821630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
    Canal CE; Morgan D; Felsing D; Kondabolu K; Rowland NE; Robertson KL; Sakhuja R; Booth RG
    J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin receptor activation inhibits sodium current and dendritic excitability in prefrontal cortex via a protein kinase C-dependent mechanism.
    Carr DB; Cooper DC; Ulrich SL; Spruston N; Surmeier DJ
    J Neurosci; 2002 Aug; 22(16):6846-55. PubMed ID: 12177182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo.
    Yadav PN; Kroeze WK; Farrell MS; Roth BL
    J Pharmacol Exp Ther; 2011 Oct; 339(1):99-105. PubMed ID: 21737536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.
    Booth RG; Fang L; Huang Y; Wilczynski A; Sivendran S
    Eur J Pharmacol; 2009 Aug; 615(1-3):1-9. PubMed ID: 19397907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
    Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
    Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced cortical serotonin 5-HT
    Mora S; Merchán A; Vilchez O; Aznar S; Klein AB; Ultved L; Campa L; Suñol C; Flores P; Moreno M
    Neuropharmacology; 2018 Dec; 143():10-19. PubMed ID: 30201211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands.
    Canal CE; Cordova-Sintjago T; Liu Y; Kim MS; Morgan D; Booth RG
    J Pharmacol Exp Ther; 2013 Dec; 347(3):705-16. PubMed ID: 24080681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT2A/C receptor blockade and mimicked by postnatal 5-HT2A/C receptor stimulation.
    Sarkar A; Chachra P; Vaidya VA
    Biol Psychiatry; 2014 Dec; 76(11):858-68. PubMed ID: 24315410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT2 Receptor Regulation of Mitochondrial Genes: Unexpected Pharmacological Effects of Agonists and Antagonists.
    Harmon JL; Wills LP; McOmish CE; Demireva EY; Gingrich JA; Beeson CC; Schnellmann RG
    J Pharmacol Exp Ther; 2016 Apr; 357(1):1-9. PubMed ID: 26787771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of 5-HT
    Casey AB; Mukherjee M; McGlynn RP; Cui M; Kohut SJ; Booth RG
    Br J Pharmacol; 2022 Jun; 179(11):2610-2630. PubMed ID: 34837227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin contracts the rat mesenteric artery by inhibiting 4-aminopyridine-sensitive Kv channels via the 5-HT2A receptor and Src tyrosine kinase.
    Sung DJ; Noh HJ; Kim JG; Park SW; Kim B; Cho H; Bae YM
    Exp Mol Med; 2013 Dec; 45(12):e67. PubMed ID: 24336234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yokukansan, a traditional Japanese herbal medicine, enhances the anxiolytic effect of fluvoxamine and reduces cortical 5-HT
    Ohno R; Miyagishi H; Tsuji M; Saito A; Miyagawa K; Kurokawa K; Takeda H
    J Ethnopharmacol; 2018 Apr; 216():89-96. PubMed ID: 29382554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex.
    Amargós-Bosch M; Bortolozzi A; Puig MV; Serrats J; Adell A; Celada P; Toth M; Mengod G; Artigas F
    Cereb Cortex; 2004 Mar; 14(3):281-99. PubMed ID: 14754868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms Underlying Serotonergic Excitation of Callosal Projection Neurons in the Mouse Medial Prefrontal Cortex.
    Stephens EK; Baker AL; Gulledge AT
    Front Neural Circuits; 2018; 12():2. PubMed ID: 29422840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reformulating a Pharmacophore for 5-HT2A Serotonin Receptor Antagonists.
    Younkin J; Gaitonde SA; Ellaithy A; Vekariya R; Baki L; Moreno JL; Shah S; Drossopoulos P; Hideshima KS; Eltit JM; González-Maeso J; Logothetis DE; Dukat M; Glennon RA
    ACS Chem Neurosci; 2016 Sep; 7(9):1292-9. PubMed ID: 27385190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of
    Jensen AA; McCorvy JD; Leth-Petersen S; Bundgaard C; Liebscher G; Kenakin TP; Bräuner-Osborne H; Kehler J; Kristensen JL
    J Pharmacol Exp Ther; 2017 Jun; 361(3):441-453. PubMed ID: 28360333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortex.
    Yuen EY; Jiang Q; Chen P; Feng J; Yan Z
    J Biol Chem; 2008 Jun; 283(25):17194-204. PubMed ID: 18442977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT
    Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Johnson RA; Janowsky A
    Biochem Pharmacol; 2018 Dec; 158():27-34. PubMed ID: 30261175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model.
    Canal CE; Booth RG; Morgan D
    Neuropharmacology; 2013 Jul; 70():112-21. PubMed ID: 23353901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.